MARKET

AGRX

AGRX

Agile Therapeutics Inc
NASDAQ
2.470
+0.310
+14.35%
After Hours: 2.390 -0.08 -3.24% 18:53 12/04 EST
OPEN
2.170
PREV CLOSE
2.160
HIGH
2.606
LOW
2.100
VOLUME
203.93K
TURNOVER
0
52 WEEK HIGH
16.00
52 WEEK LOW
1.650
MARKET CAP
6.20M
P/E (TTM)
0.1807
1D
5D
1M
3M
1Y
5Y
Agile Therapeutics Inc: Current report
Press release · 1d ago
Weekly Report: what happened at AGRX last week (1127-1201)?
Weekly Report · 1d ago
Weekly Report: what happened at AGRX last week (1120-1124)?
Weekly Report · 11/27 09:58
Agile Therapeutics reports Q3 results
Agile therapeutics reports q3 net revenue of $6.7 million, up 122% from the year-ago third quarter. Non-gaap net loss of $4.3 million or $1.47 per share in the third quarter of 2023.
Seeking Alpha · 11/22 14:26
Analysts Are Bullish on Top Healthcare Stocks: Mainz Biomed B.V. (MYNZ), Agile Therapeutics (AGRX)
TipRanks · 11/21 17:20
Weekly Report: what happened at AGRX last week (1113-1117)?
Weekly Report · 11/20 09:57
Weekly Report: what happened at AGRX last week (1106-1110)?
Weekly Report · 11/13 09:54
Agile Therapeutics: A Promising Investment with Positive Cash Flow Forecasts and Anticipated Growth in Twirla Sales
TipRanks · 11/10 19:05
More
About AGRX
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The Company commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.

Webull offers Agile Therapeutics Inc stock information, including NASDAQ: AGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGRX stock methods without spending real money on the virtual paper trading platform.